Veradermics MANE
NYSE MANE
$116.74 -0.51 (-0.43%)
At close: Oct 2, 2026 · 4:00 PM EDT

Veradermics (MANE) Income towards Parent Company (2025 - 2026)

Updated

Veradermics' Income towards Parent Company was -$23.5 million in Q2 2026, compared with -$15.65 million a year earlier.

Analysis

Veradermics (MANE) Income towards Parent Company (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Veradermics' Income towards Parent Company was -$78.78 million through Jun 30, 2026; for FY2025, it came in at -$70 million.

  • In earlier years, Income towards Parent Company was -$26.5 million in FY2024.
  • Quarterly Income towards Parent Company has moved between -$27.23 million (Q1 2026) and -$12.4 million (Q1 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Veradermics 4.88 Bn 4.88 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.50 Mn
Mar 31, 2026 -27.23 Mn
Jun 30, 2025 -15.65 Mn
Mar 31, 2025 -12.40 Mn
API Access

Veradermics Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=MANE&period=max&api_key=YOUR_API_KEY